ArticleOncotarget2017

The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy.

Jinge Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.